Loading...
OTCM
BRAXF
Market cap362kUSD
Jul 09, Last price  
0.00USD
1D
0.00%
1Q
42.22%
IPO
-99.46%
Name

Braxia Scientific Corp

Chart & Performance

D1W1MN
OTCM:BRAXF chart
P/E
—
P/S
0.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
2m
+26.70%
2121,008,3721,487,1561,884,171
Net income
-13m
L+8.30%
-172,723-88,828,146-12,134,091-13,141,704
CFO
-7m
L+63.75%
-288,831-5,056,130-4,518,400-7,399,035

Profile

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.
URL
https://braxiascientific.com/
IPO date
Feb 27, 2020
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFY
2023‑032022‑032021‑032020‑03
Income
Revenues
1,884
26.70%
Cost of revenue
7,434
Unusual Expense (Income)
NOPBT
(5,550)
NOPBT Margin
Operating Taxes
(146)
Tax Rate
NOPAT
(5,404)
Net income
(13,142)
8.30%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,264
BB yield
Debt
Debt current
76
Long-term debt
233
Deferred revenue
Other long-term liabilities
Net debt
(1,194)
Cash flow
Cash from operating activities
(7,399)
CAPEX
(827)
Cash from investing activities
(1,128)
Cash from financing activities
1,236
FCF
(6,055)
Balance
Cash
1,462
Long term investments
41
Excess cash
1,409
Stockholders' equity
1,529
Invested Capital
403
ROIC
ROCE
EV
Common stock shares outstanding
228,421
Price
Market cap
EV
EBITDA
(4,984)
EV/EBITDA
Interest
18
Interest/NOPBT